The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Ranked by engagement

Top topics — all time page 37

Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.

1,535 topics · page 37 of 40

TopicParticipantsRepliesViewsActivity
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold?
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Two things I would like separated…
ARJENGMVMD+19 23 4.2k 19mo
Why I now write the concentration on the vial in marker
Asking directly, because I could not find a straight answer: Why I now write the concentration on the vial in marker Writing this out with the numbers in it, because "roughly" is how these go wrong. Vial: 15…
CRAITHCAEF+1 5 30k 11d
Titrating on tolerability rather than on the calendar
On the subject in the title: Titrating on tolerability rather than on the calendar Working notes rather than a conclusion. An honest uncertainty about titrating on tolerability rather than a disguised…
POCCMH 2 31k 13mo
Specification in the result column: why that is a meaningful error — the long version
Specification in the result column: why that is a meaningful error — the long version Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an…
MPGRATYAH+14 18 12k 17mo
Appeal templates and why they are deliberately unemotional
Posting this under the heading it deserves: Appeal templates and why they are deliberately unemotional Everything below is what sits behind that. A narrow question about appeal templates, deliberately narrow,…
DOTNCSBAE+25 29 764 7mo
[2026 update] Documenting an adverse event properly
Documenting an adverse event properly Writing it up because I had to work it out twice and would rather nobody else did. Asking about Documenting an adverse event on behalf of the question I keep seeing asked…
TPTITDKAF+18 22 4.3k 1d
Early satiety becoming a problem rather than a benefit
Early satiety becoming a problem rather than a benefit — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about early satiety. Everyone…
LCJMPYEST+20 24 2.5k 6mo
[2026 update] Heterogeneity as information rather than as a nuisance
Heterogeneity as information rather than as a nuisance Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a claim I…
PSGCCFDCL 4 32k 11mo
Substitution between formats during a shortage — what changed since
Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Substitution between formats…
SBKACONKWN+17 21 2.7k 9d
Talking to a therapist about this specifically
Posting this under the heading it deserves: Talking to a therapist about this specifically Everything below is what sits behind that. Something that has come up for me and that I suspect is more common than…
SSVBTVJADB+20 24 855 14h
About the Pharmacokinetics category
Half-life, accumulation, steady state, albumin binding, and why weekly dosing works. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
KTVSMNARF 4 32k 8mo
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset
Posting this under the heading it deserves: Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Everything below is what sits behind that. Posting a small dataset on STEP 8. It is…
OLIADSRFDO+18 22 656 13h
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold?
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. A narrow question about semaglutide…
BDBEMVD 3 28k 6mo
Coming back to: What consumer-accessible tests can and cannot determine
Asking directly, because I could not find a straight answer: What consumer-accessible tests can and cannot determine Something about consumer-accessible tests does not reconcile and I would like a second pair…
PKNWVNHK+4 8 25k 22mo
NHS criteria and how they are applied in practice — the long version
Posting this under the heading it deserves: NHS criteria and how they are applied in practice — the long version Everything below is what sits behind that. A narrow question about NHS criteria, deliberately…
RLJIWTGBST+11 15 11k 9mo
GIP receptor agonism and the argument about direction — does this still hold?
GIP receptor agonism and the argument about direction — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. A question about GIP receptor agonism…
HMBNSCPWEL+10 14 15k 16h
Absolute versus relative contraindications
On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. Proposing that absolute versus relative contraindications deserves a maintained page rather than…
HNBRMALFN+4 8 23k 8mo
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
EAASVBSDFW+17 22 4.5k 1d
Rewriting my first post: a before-and-after, with commentary — what changed since
Posting this under the heading it deserves: Rewriting my first post: a before-and-after, with commentary — what changed since Everything below is what sits behind that. I want to check my reasoning rather…
SLDEMSBVPE+15 19 12k 13h
Where to report an adverse event officially, by region
Where to report an adverse event officially, by region Writing it up because I had to work it out twice and would rather nobody else did. Reporting an event with the dates and the sequence, because…
FPSCII 2 27k 1h
Why 99.2% and 97.8% on the same lot can both be correct
Why 99.2% and 97.8% on the same lot can both be correct I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means before I…
GHAAJSLCCR+16 20 3.1k 11h
Batch date after test date, and other internal inconsistencies
Batch date after test date, and other internal inconsistencies — setting out what I have, and where I think it stops being reliable. Proposing that batch date deserves a maintained page rather than a…
VODMTBBTAM+27 31 4.9k 7mo
[2026 update] Distinguishing expected GI effects from something that needs urgent attention
On the subject in the title: Distinguishing expected GI effects from something that needs urgent attention Working notes rather than a conclusion. Reporting something rather than asking about it, in case the…
IIMMBDFI+10 14 11k 4mo
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Writing it up because I had to work it out twice and would rather nobody else did. A methods question rather than a substantive…
HFITVAKLV+10 14 8.4k 16h
Comparators chosen for regulatory reasons rather than clinical ones
On the subject in the title: Comparators chosen for regulatory reasons rather than clinical ones Working notes rather than a conclusion. An honest uncertainty about comparators chosen for regulatory reasons…
PESZTD 2 27k 14mo
Second pass at: Domestic fridge temperature mapping: a cheap experiment
Posting this under the heading it deserves: Second pass at: Domestic fridge temperature mapping: a cheap experiment Everything below is what sits behind that. Two things I would like separated before anyone…
DBEMET 2 30k 16mo
[2026 update] Building a sensible monitoring schedule with your prescriber
Posting this under the heading it deserves: Building a sensible monitoring schedule with your prescriber Everything below is what sits behind that. Reading back through what has been written here about…
NKAWTSKAAD+22 26 5.1k 14mo
Revisiting: What to include when your question involves arithmetic
Revisiting: What to include when your question involves arithmetic — setting out what I have, and where I think it stops being reliable. Counting it rather than describing it, because the count is the part…
GRTTJCJSLC+21 25 384 12mo
Second pass at: I joined for one answer and stayed for a year — what changed my mind
Second pass at: I joined for one answer and stayed for a year — what changed my mind — setting out what I have, and where I think it stops being reliable. Question in the title and the context underneath, in…
NPDBJJFIL 4 25k 2mo
Cleaning a self-reported dataset and what you throw away
Cleaning a self-reported dataset and what you throw away — setting out what I have, and where I think it stops being reliable. Collecting what is known about cleaning a self-reported dataset in one place,…
SCFISC 2 28k 1d